2nd Annual Wisconsin Primary CNS Malignancy Symposium (Virtual Activity)
The goal of this educational activity is to present a multi-disciplinary approach to the clinical management of meningioma, discuss available innovative clinical trial options and ideas for future clinical trials, and provide the latest updates on current treatment trends in neurosurgery, radiation oncology, and neuro-oncology. Using a disease-orientated multi-disciplinary approach, along with panel discussions, the activity will provide a comprehensive update for providers from multiple disciplines.
Intended Audience
This activity is designed to educate community general practitioners, oncologists, radiation oncologists, neurosurgeons, advanced practice nurses, PAs, RNs and other healthcare providers on topics relevant to new advances in the diagnosis and treatment of meningiomas.
Learning Objectives
The global learning objectives for this activity are as follows.
By participating in this activity members of the health care team will be able to:
- Describe new neurosurgical advances and techniques in the management of meningioma.
- Report updates and controversies in the treatment of meningioma.
- Describe the importance of pathology and integrated molecular diagnosis for meningioma.
- Summarize quality of life metrics as identified by patients.
- List innovative clinical trials available for meningioma and their eligibility criteria.
Saturday, April 23, 2022 All times listed are in Central Daylight Time (CDT) | |
7:45 AM - 8:00 AM | Welcome |
Clinical Management Malignant Glioma Moderator: | |
8:00 AM - 8:30 AM | Surgery |
8:35 AM - 9:05 AM | Radiation Oncology Planning Advances |
9:05 AM - 9:35 AM | Protons |
9:35 AM - 10:05 AM | Surgery |
10:05 AM - 10:15 AM | Panel Discussion |
10:15 AM - 10:30 AM | Break & Exhibitors |
Clinical Management: Moderator: | |
10:30 AM - 11:30 AM | Translational Science |
11:30 AM - 12:00 PM | Pathology |
12:00 PM - 12:40 PM | QOL |
12:40 PM - 1:00 PM | Panel Discussion |
1:00 PM | Adjourn |
POLICY ON DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
Mahua Dey, MD | Course Director | No relevant relationships with ineligible companies to disclose | No |
Joseph Bovi, MD | Course Director | No relevant relationships with ineligible companies to disclose | No |
Brittany Burroughs | Planner | No relevant relationships with ineligible companies to disclose | No |
Sara Scott, BSc | Accreditation Specialist | No relevant relationships with ineligible companies to disclose | No |
Manish Aghi | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Jeffrey Helgager | Speaker/Author | Biontech (Stock), Pfizer Inc. (Stock), Moderna (Stock) | No |
Rupesh Kotecha | Speaker/Author | Exelixis (Grant / Contract), GT Medical Technologies, Inc (Grant / Contract), Novocure Inc. (Grant / Contract), AstraZeneca (Grant / Contract), Novocure Inc. (Independent Contractor - Consultant), Accuray Incorporated (Independent Contractor - Consultant), Elekta (Independent Contractor - Consultant), Medtronic (Grant / Contract), Elsevier (Independent Contractor - Consultant), Brainlab, Inc. (Grant / Contract), Brainlab, Inc. (Independent Contractor - Consultant), Blue Earth Diagnostics Limited (Grant / Contract), VIEWRAY TECHNOLOGIES INC (Grant / Contract), VIEWRAY TECHNOLOGIES INC (Independent Contractor - Consultant) | No |
Michael McDermott | Speaker/Author | InSightec,LTD (Independent Contractor - Consultant), Zap Surgical Systems, Inc. (Stock Option), Deinde Medical (Independent Contractor - Consultant), Stryker Corporation (Independent Contractor - Consultant) | No |
Joshua Palmer | Speaker/Author | No relevant relationships with ineligible companies to disclose | Yes |
Gelareh Zadeh | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Nathan Zwagerman | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
Accreditation Statement In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Medical College of Wisconsin (MCW). The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. | |
American Medical Association (AMA) The University of Wisconsin–Madison ICEP designates this virtual live activity for a maximum of 4.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. American Nurses Credentialing Center (ANCC) The University of Wisconsin–Madison ICEP designates this virtual live activity for a maximum of 4.75 ANCC contact hours. Continuing Education Units (CEUs) The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.475 CEUs or 4.75 hours. |
Available Credit
- 4.75 AMA PRA Category 1 Credit™
- 4.75 ANCC Contact Hours
- 4.75 University of Wisconsin–Madison Continuing Education Hours
- 4.75 Approved for AMA PRA Category 1 Credit™
REGISTRATION FEES
$50.00 MD/DO
$25.00 RN, APRN, PA, and other healthcare providers
$0.00 Trainees, including fellows, residents and students
COURSE MATERIALS
Course materials will be posted on this site.
CANCELLATION AND REFUND POLICY
Requests for cancellation must be submitted in writing to help@icep.wisc.edu. Cancellation requests received at least 96 hours prior to the conference will allow a full refund except for the $10 non-refundable processing fee. No refunds will be made for cancellations received less than 96 hours prior to the activity start date.
QUESTIONS ABOUT REGISTRATION
Email help@icep.wisc.edu
PROGRAM CHANGES
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin–Madison ICEP reserves the right to alter or substitute a topic or speaker without prior notification.
ACCESSIBILITY
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at help@icep.wisc.edu
FOR FURTHER INFORMATION
For conference information or details, please contact Brittany Burroughs, burroughs@neurosurgery.wisc.edu.
REQUIRED HARDWARE/SOFTWARE
Computer, tablet, or smartphone with audio sharing capabilities.